 | 
 | |
 
- November 16, 2011 - Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint » Read
- November 14, 2011 - Nile Therapeutics Reports 2011 Third Quarter Financial Results » Read
- October 18, 2011 - Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients » Read
- September 8, 2011 - Nile Therapeutics to Present at Rodman & Renshaw Global Investment Conference » Read
- June 24, 2011 - Nile Therapeutics Provides Update on Ongoing Phase I Clinical Trial of Cenderitide » Read
- June 23, 2011 - Nile Therapeutics, Inc. Completes $2.5 Million Private Placement » Read
- June 21, 2011 - Nile Therapeutics, Inc. To Raise $2.5 Million in Private Placement » Read
- May 16, 2011 - Nile Therapeutics Reports 2011 First Quarter Financial Results » Read
- May 3, 2011 - Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide » Read
- March 31, 2011 - Nile Therapeutics Receives Fast Track Designation for Cenderitide for Post-Acute Indication » Read
- March 30, 2011 - Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting » Read
- March 14, 2011 - Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results » Read
- March 2, 2011 - Nile Therapeutics Receives Positive NASDAQ Panel Decision » Read
- February 28, 2011 - Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease » Read
- February 28, 2011 - Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure » Read
| |
|
